Loading prices...
All news
Flat vector illustration of a glowing triangle containing a lens, a DNA helix, and a cell shape stacked vertically, symbolizing three digest stories: surveillance, cloning, and children's cell mapping

The Download: Flock's loophole, cloning's future, kids' cells

Three stories worth your attention today: a police-tech giant tightens rules after a stalking scandal, scientists lay out what cloning might actually be good for, and researchers try to map how children's cells differ from adults'.

Flock, the company behind a nationwide network of license-plate readers used by law enforcement, is changing how officers access its database after a backlash over mass surveillance and reports of officers using the system to track or harass current or former romantic partners. Officers will now need to enter a criminal case number before running a search, and Flock is expanding automated auditing of searches that look suspicious. The catch: Flock won't verify that the case numbers officers enter are real, so an officer determined to misuse the system could still type in a fabricated number and search anyway.

On the science side, researchers Takashi Ishiuchi and Shogo Matoba, who developed a CRISPR-based method to remove the Y chromosome from male mouse embryos and produce fertile female clones, described earlier as a research breakthrough in an earlier edition of this digest, spoke about where the technique could actually go next. They see conservation as the clearest use case, pointing to past cloning successes with black-footed ferrets and Przewalski's horses, and a more fraught 2009 attempt to clone the extinct Pyrenean ibex. The interview also surfaced a far more unsettling pitch from a biotech startup founder: using cloning to grow brainless human bodies purely as organ sources for transplants. Bioethicist Jessica Pierce raised a separate concern closer to home, describing commercial pet cloning as exploitation with no real medical or environmental justification.

The third story is quieter but has real clinical stakes: Deanne Taylor is building a cellular map of childhood as part of the Human Cell Atlas project, which originally focused only on adult tissue. Children's cells express genes differently than adult cells do, which can mean a drug that's safe and effective in adults produces a different, sometimes dangerous, response in a child. A baseline map of healthy pediatric tissue would give researchers a reference point for understanding both normal childhood development and how adult-onset diseases might trace back to changes that started much earlier in life.

  • Flock now requires officers to enter a case number before searching its license-plate database, but doesn't verify the numbers are real
  • The change follows reports of officers using the system to track or harass romantic partners
  • Scientists behind a Y-chromosome-removal mouse cloning technique point to conservation as the clearest application
  • A biotech founder's pitch for brainless human clones as organ sources drew sharp pushback in the same reporting
  • The Human Cell Atlas project is being extended to map children's cells, which behave differently from adult cells in ways that affect drug safety

The three stories share a common thread: technology built for one clear purpose, whether locating a stolen car, saving an endangered species, or mapping human biology, keeps opening doors nobody fully planned for. A safeguard that isn't actually verified isn't much of a safeguard, a cloning technique developed for conservation invites pitches its creators probably didn't anticipate, and a cell atlas built for adults turns out to have left out a third of the population whose biology doesn't map cleanly onto the adult baseline. None of that makes the underlying tools bad; it just means the interesting part of each story tends to live in the gap between what a technology was built to do and what people actually try to do with it.

None of this should be read as personalized investment advice.

Published: 19:00 · 14.08.2026
Maks

Author

Maks

Trading man

I've been interested in the cryptocurrency market for a long time, am a trader, and write articles and news about my experience and crypto in simple terms.

Comments (0)

No comments yet — be the first!